⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 14, 2020European Journal of Drug Metabolism and PharmacokineticsOpen Access

A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

ACTRN12618001424291. Registered August 2018.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Perkins et al. (2020) studied this question.

synapsesocial.com/papers/69d76f5faa68b335b4f316ec https://doi.org/10.1007/s13318-020-00624-6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet SyndromeRCT · 2017 · 1,717 citations
2Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromesCohort Study · 2018 · 191 citations
3Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a multi-center, randomized, double-blind, placebo controlled trial (GWPCARE4) (S21.001)RCT · 2017 · 23 citations
4Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program resultsCohort Study · 2018 · 206 citations
5Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppressionOriginal Research · 2006 · 496 citations